Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients.
Sieta T de VriesPetra DenigCarmen Lasheras RuizFrançois HouÿezLisa WongAlastair SutcliffePeter G M Molnull nullPublished in: Drug safety (2018)
An app is positively perceived by HCPs and patients for reporting ADRs quickly and for receiving drug safety information from national medicines agencies. In particular, HCPs and patients who already use other health apps were interested in the app.